Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Charles River Laboratories Intl. Inc (CRL) vs M&T Bank Corporation (MTB) Price & Performance

Charles River Laboratories Intl. IncTrade
M&T Bank CorporationTrade

Price performance (Past 24H)

Key statistics

Charles River Laboratories Intl. Inc vs M&T Bank Corporation — how do they compare? Charles River Laboratories Intl. Inc trades at $231 (market cap $11.14B), while M&T Bank Corporation trades at $246.29 (market cap $35.42B). The key difference: M&T Bank Corporation is far larger — about 3.2× Charles River Laboratories Intl. Inc's market cap, and M&T Bank Corporation pays a 2.48% dividend while Charles River Laboratories Intl. Inc pays none. Which is the better fit depends on your goals.

CRLMTB
Market Cap
$11.14B$35.42B
Sector
HealthFinancials
52-Week High
$233.60$242.55
52-Week Low
$145.57$178.63
Enterprise Value
$14.00B
Dividend Yield
2.48%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Charles River Laboratories Intl. Inc

No Aura AI signal available yet.

M&T Bank Corporation

M&T Bank Corporation (MTB) trades at $242.55, up 0.09% today, with a bullish technical signal supported by moving averages. The stock shows consistent earnings beats, with Q1 2026 EPS of $4.18 exceeding expectations of $4.02. Revenue grew to $9.63B in 2025, with a net income margin of 29.59%. Recent news highlights Q2 2026 results announcement on July 15, 2026, with expectations of higher net interest income and loan growth.

Outlook remains positive due to strong profitability and dividend stability, but risks include elevated costs and net cash flow volatility. Analyst consensus is mixed with 29% buy ratings, though the price target of $242.72 suggests limited upside from current levels. Investors should weigh solid fundamentals against macroeconomic sensitivity.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Charles River Laboratories Intl. Inc

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

Read more on CRL

About M&T Bank Corporation

M&T Bank is one of the largest regional banks in the United States, with branches in New York, Pennsylvania, West Virginia, Virginia, Maryland, Delaware, and New Jersey. The bank was founded to serve manufacturing and trading businesses around the Erie Canal and is primarily focused on commercial real estate and commercial-related lending, with some retail operations also present.

Read more on MTB